Device Trial Radar · NCT03366779
A Post Marketing Surveillance Study
Last checked: Nov 20, 2026Latest source record: Mar 15, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
20
Actual
Start
Jan 16, 2018
Primary completion
Jun 2024
Study completion Dec 2024
Sponsor
- Lead sponsor
- Intrinsic TherapeuticsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 8, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a prospective, multi-center study to monitor the early safety and performance of one iteration of the Barricaid Anular Closure Device (ACD) - 6mm anchor width, when used as an adjunct to limited discectomy.
Conditions
- Lumbar Disc Herniation
- Annular Disc Tear
- Annular Tear of Lumbar Disc
Interventions
6mm annular closure deviceDevice
6MM Barricaid annular closure device implantation following standard lumbar discectomy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Device stabilityTime frame: 3 months post implantation
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
OLVZ Aalst
Aalst, Belgium
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.